Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,528 | -3,057 | -5,263 | -44,078 | -51,647 |
| Depreciation Amortization | N/A | N/A | N/A | 65 | 472 |
| Accounts receivable | -444 | -556 | 96 | 4 | 27 |
| Accounts payable and accrued liabilities | 118 | -445 | -1,772 | 1,142 | 393 |
| Other Working Capital | -227 | -1,538 | -4,601 | -2,850 | 1,408 |
| Other Operating Activity | 767 | 1,263 | -9,705 | 5,106 | 12,830 |
| Operating Cash Flow | $-3,314 | $-4,333 | $-21,245 | $-40,611 | $-36,517 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | 1,457 |
| Other Investing Activity | 0 | 0 | 10,402 | 0 | 0 |
| Investing Cash Flow | $0 | $0 | $10,402 | $N/A | $1,457 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 24 | 29 | 282 |
| Common Stock Repurchased | N/A | N/A | 5,000 | N/A | N/A |
| Other Financing Activity | 3,322 | 0 | 0 | 0 | 30,503 |
| Financing Cash Flow | $3,322 | $0 | $5,024 | $29 | $30,785 |
| Exchange Rate Effect | 0 | -6 | 8 | 3 | 4 |
| Beginning Cash Position | 3,232 | 7,571 | 13,382 | 53,961 | 58,232 |
| End Cash Position | 3,240 | 3,232 | 7,571 | 13,382 | 53,961 |
| Net Cash Flow | $8 | $-4,339 | $-5,811 | $-40,579 | $-4,271 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,314 | -4,333 | -21,245 | -40,611 | -36,517 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -7 |
| Free Cash Flow | -3,314 | -4,333 | -21,245 | -40,611 | -36,524 |